-
Aerial BioPharma LLC, Morrisville, N.C. Product: ADX-N05, ARL-N05 Business: Neurology Molecular target: NA Description: NA Indication: Treat excessive daytime sleepiness in patients with narcolepsy Endpoint: Change from…
Published on 6/17/2013
-
CytRx Corp. (NASDAQ:CYTR), Los Angeles, Calif. Product: Aldoxorubicin (formerly DOXO-EMCH, INNO-206) Business: Cancer Molecular target: DNA Description: 6-maleimidocaproyl hydrazone prodrug of doxorubicin Indication: …
Published on 6/17/2013
-
CytRx Corp. (NASDAQ:CYTR), Los Angeles, Calif. Product: Aldoxorubicin (formerly DOXO-EMCH, INNO-206) Business: Cancer Molecular target: DNA Description: 6-maleimidocaproyl hydrazone prodrug of doxorubicin Indication: …
Published on 6/17/2013
-
Celgene Corp. (NASDAQ:CELG), Summit, N.J. Product: Apremilast (CC-10004) Business: Inflammation Molecular target: Phosphodiesterase-4 (PDE-4); Interleukin-2 (IL-2) Description: Oral phosphodiesterase-4 (PDE-4) inhibitor…
Published on 6/17/2013
-
Celgene Corp. (NASDAQ:CELG), Summit, N.J. Product: Apremilast (CC-10004) Business: Autoimmune Molecular target: Phosphodiesterase-4 (PDE-4); Interleukin-2 (IL-2) Description: Oral phosphodiesterase-4 (PDE-4) inhibitor …
Published on 6/17/2013
-
Celgene Corp. (NASDAQ:CELG), Summit, N.J. Product: Apremilast (CC-10004) Business: Autoimmune Molecular target: Phosphodiesterase-4 (PDE-4); Interleukin-2 (IL-2) Description: Oral phosphodiesterase-4 (PDE-4) inhibitor …
Published on 6/17/2013
-
Genentech Inc., South San Francisco, Calif. Chugai Pharmaceutical Co. Ltd. (Tokyo:4519), Tokyo, Japan Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Product: Avastin bevacizumab (RG435) Business: Cancer Molecular …
Published on 6/17/2013
-
Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI), Henderson, Nev. Topotarget A/S (CSE:TOPO), Copenhagen, Denmark Product: Belinostat (IV PXD101) Business: Cancer Molecular target: Histone deacetylase (HDAC) Description: …
Published on 6/17/2013
-
Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI), Henderson, Nev. Topotarget A/S (CSE:TOPO), Copenhagen, Denmark Product: Belinostat (IV PXD101) Business: Cancer Molecular target: Histone deacetylase (HDAC) Description: …
Published on 6/17/2013
-
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Novato, Calif. Product: BMN 673, BMN-673 (formerly LT-673) Business: Cancer Molecular target: Poly(ADP-ribose) polymerase (PARP) Description: Poly(ADP-ribose) polymerase (PARP…
Published on 6/17/2013
-
Bionomics Ltd. (ASX:BNO; OTCBB:BMICY), Thebarton, Australia Product: BNC105 Business: Cancer Molecular target: Tubulin Description: Vascular disrupting agent (VDA) with direct cytotoxic activity Indication: Treat …
Published on 6/17/2013
-
Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Product: Brodalumab (formerly AMG 827) Business: Autoimmune Molecular target: Interleukin-17 (IL-17) receptor (IL17R) (…
Published on 6/17/2013
-
Cell Therapeutics Inc. (NASDAQ:CTIC; Milan:CTIC), Seattle, Wash. Product: Brostallicin Business: Cancer Molecular target: DNA Description: Synthetic DNA minor groove binding agent Indication: Treat metastatic triple-…
Published on 6/17/2013
-
EpiCept Corp. (OTCQX:EPCT; SSE:EPCT), Tarrytown, N.Y. Product: Crolibulin (EPC2407) (formerly crinobulin) Business: Cancer Molecular target: Tubulin Description: Small molecule vascular disruption agent (VDA) and …
Published on 6/17/2013
-
Celltrion Inc. (KOSDAQ:068270), Incheon, South Korea Hospira Inc. (NYSE:HSP), Lake Forest, Ill. Nippon Kayaku Co. Ltd. (Tokyo:4272), Tokyo, Japan Product: CT-P13 (Remsima, Infliximab) Business: Autoimmune Molecular …
Published on 6/17/2013
-
Bavarian Nordic A/S (CSE:BAVA), Kvistgaard, Denmark Product: CV-301, CVAC-301 (formerly Panvac) Business: Cancer Molecular target: Carcinoembryonic antigen (CEA); Mucin 1 (MUC1) (CD227) Description: Vaccine targeting …
Published on 6/17/2013
-
DCPrime B.V., Amsterdam, the Netherlands Product: DCP-001 Business: Cancer Molecular target: Not applicable Description: Off-the-shelf dendritic cell vaccine based on DCOne technology Indication: Treat acute myelogenous…
Published on 6/17/2013
-
Castle Biosciences Inc., Friendswood, Texas Product: DecisionDx-Melanoma test Business: Diagnostic Molecular target: NA Description: Real-time PCR test that analyzes the expression of 31 genes from formalin-fixed, …
Published on 6/17/2013
-
Boehringer Ingelheim GmbH, Ingelheim, Germany Product: Deleobuvir (BI 207127) Business: Infectious Molecular target: HCV NS5B polymerase Description: Oral non-structural protein 5B (NS5B) RNA-dependent polymerase …
Published on 6/17/2013
-
Dendreon Corp. (NASDAQ:DNDN), Seattle, Wash. Product: DN24-02 Business: Cancer Molecular target: Epidermal growth factor receptor 2 (EGFR2) (HER2) (ErbB2) (neu) mRNA Description: Autologous cellular immunotherapy …
Published on 6/17/2013
-
Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Pfizer Inc. (NYSE:PFE), New York, N.Y. Product: Enbrel etanercept Business: Autoimmune Molecular target: Tumor necrosis factor (TNF) alpha; Lymphotoxin alpha Description: …
Published on 6/17/2013
-
Immunomedics Inc. (NASDAQ:IMMU), Morris Plains, N.J. Product: Epratuzumab-Rap Business: Cancer Molecular target: CD22 Description: Humanized mAb targeting CD22 fused to an amphibian RNase using dock and lock (DNL) …
Published on 6/17/2013
-
Emory University, Atlanta, Ga. Product: Escitalopram Business: Neurology Molecular target: Serotonin (5-HT) transporter (SLC6A4) (SERT) Description: Allosteric selective serotonin reuptake inhibitor (SSRI) Indication: …
Published on 6/17/2013
-
Boehringer Ingelheim GmbH, Ingelheim, Germany Product: Faldaprevir (BI 201335) Business: Infectious Molecular target: HCV NS3/4A protease complex Description: Oral HCV NS3/4A protease inhibitor Indication: Treat chronic…
Published on 6/17/2013
-
NewLink Genetics Corp. (NASDAQ:NLNK), Ames, Iowa Product: Indoximod (1-MT) (NLG8189) 1-methyl-D-tryptophan Business: Cancer Molecular target: Indoleamine 2,3-dioxygenase (INDO) (IDO) Description: Indoleamine 2,3-…
Published on 6/17/2013